Patents by Inventor Claudio Rigatto

Claudio Rigatto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12186753
    Abstract: Described herein is a method for mixing unequal amounts of two reagents to produce a detectable reaction in a microfluidic chip. In one example, there is a fluorescent microfluidic urinary albumin chip (UAL-Chip) that exploits the nonimmunological fluorescent assay. In this chip, we constructed a passive and continuous mixing module, in which the loading process requires only an inexpensive dropper, and the signal is stable over time, as discussed below. We applied a pressure-balancing strategy based on the immiscible oil coverage which highly improves the precision in controlling the mixing ratio of sample and dye. The UAL-Chip has achieved an estimated limit of detection (LOD) of 8.4 ?g/ml using albumin standards, which is below the 30 ?g albumin per ml urine level considered to be indicative of kidney damage.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: January 7, 2025
    Assignee: University of Manitoba
    Inventors: Francis Lin, Jiandong Wu, Claudio Rigatto, Paul Komenda, Navdeep Tangri, Gong Zhang
  • Publication number: 20210308680
    Abstract: Described herein is a method for mixing unequal amounts of two reagents to produce a detectable reaction in a microfluidic chip. In one example, there is a fluorescent microfluidic urinary albumin chip (UAL-Chip) that exploits the nonimmunological fluorescent assay. In this chip, we constructed a passive and continuous mixing module, in which the loading process requires only an inexpensive dropper, and the signal is stable over time, as discussed below. We applied a pressure-balancing strategy based on the immiscible oil coverage which highly improves the precision in controlling the mixing ratio of sample and dye. The UAL-Chip has achieved an estimated limit of detection (LOD) of 8.4 ?g/ml using albumin standards, which is below the 30 ?g albumin per ml urine level considered to be indicative of kidney damage.
    Type: Application
    Filed: September 24, 2019
    Publication date: October 7, 2021
    Inventors: Francis Lin, Jiandong Wu, Claudio Rigatto, Paul Komenda, Navdeep Tangri, Gong Zhang